Management Team

Michael Breen

Michael Breen

Executive Chairman, Board of Directors, Interim Chief Executive Officer

Michael Breen is an English qualified solicitor/attorney and was formerly the Managing Director of the Sports and Entertainment Division of Bank Insinger de Beaufort N. V., which is a wealth management organization and was part of BNP Paribas Group, one of the world's largest banks. The holding company Insinger de Beaufort Holdings S.A. was listed on the Luxembourg Stock Exchange. Mr. Breen was also a director and major shareholder of an affiliate of Insinger de Beaufort Holdings S.A.

Mr. Breen is a former senior equity partner in the 400+ partner and 50+ office law firm of Clyde & Co, whose head office is based in the City of London, England.

Manu Ohri

Manu Ohri

Chief Financial Officer

Mr. Ohri, an accomplished accounting and finance executive brings to GT Biopharma over 25 years of management, finance and public accounting experience in working with Board of Directors, capital markets, independent auditors and attorneys. Mr. Ohri, served as CFO for multiple public companies began his career in public accounting as an auditor for PricewaterhouseCoopers and subsequently for Deloitte & Touche in excess of seven years. He is a licensed CPA and received his MBA with a concentration in Accounting and Finance from the University of Detroit. Prior to this appointment, he served as a management consultant advising both privately held and publicly traded companies in numerous sectors including biotech and pharmaceuticals. Prior to his role as a management consultant, Mr. Ohri served as the CFO and a member of the Board of Directors of ToughBuilt Industries, Inc., a NASDAQ listed company serving global markets.

Jeffrey S. Miller, M.D.

Jeffrey S. Miller, M.D.

Consulting Chief Medical Officer and Chief Scientific Officer

Jeffrey S. Miller, MD, received a Bachelor of Science degree from Northwestern University in Evanston, Illinois and received his MD from Northwestern University School of Medicine. He completed an internship and residency in Internal Medicine at the University of Iowa in Iowa City. After completing a post-doctoral fellowship in Hematology, Oncology and Transplantation at the University of Minnesota, he joined the faculty in 1991. Dr. Miller is currently a Professor of Medicine at the University of Minnesota. He is the Deputy Director of the University of Minnesota Masonic Comprehensive Cancer Center. He has more than 20 years of experience studying the biology of NK cells and other immune effector cells and their use in clinical immunotherapy with over 170 peer-reviewed publications. He is a member of numerous societies such as the American Society of Hematology, the American Association of Immunologists, a member of the American Society of Clinical Investigation since 1999. He serves on the editorial board for Blood and is a reviewer for a number of journals and NIH grants.